BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260818
DTEND;VALUE=DATE:20260828
DTSTAMP:20260725T054714Z
CREATED:20260724T211527Z
LAST-MODIFIED:20260725T054714Z
UID:10856-1787011200-1787875199@thebiocalendar.com
SUMMARY:The Matrix One West Coast MedTech Forum
DESCRIPTION:The Matrix One West Coast MedTech Forum is a free series of expert roundtables\, educational sessions and networking events taking place across California from 18 to 27 August 2026. Designed for professionals throughout the MedTech and life sciences community\, the programme brings together regulatory affairs\, quality\, engineering\, product\, digital health and business leaders. \nAttendees will explore some of the most important issues shaping medical device development\, including practical applications of AI\, regulatory submissions\, design control\, audit readiness\, quality management\, cloud connectivity\, cybersecurity and compliant product development. Events will take place across San Francisco\, Palo Alto\, Redwood City\, Los Angeles\, Irvine and San Diego\, featuring insights from industry experts\, legal specialists\, former FDA professionals and local MedTech leaders\, alongside valuable opportunities to connect with peers.
URL:https://thebiocalendar.com/event/the-matrix-one-west-coast-medtech-forum/
LOCATION:California (multiple locations)\, CA\, United States
CATEGORIES:Forum
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260820T110000
DTEND;TZID=America/Los_Angeles:20260820T120000
DTSTAMP:20260725T055053Z
CREATED:20260717T115757Z
LAST-MODIFIED:20260725T055053Z
UID:10796-1787223600-1787227200@thebiocalendar.com
SUMMARY:FDA Engagement Strategies And Best Practices Amid Agency Changes
DESCRIPTION:How can life sciences companies developing new medicines engage the FDA successfully during a period of rapid changes in agency personnel and policies? \nShould companies adjust their agency communication strategies or ask new questions during meetings? Our deeply experienced panelists will discuss key changes at the FDA\, how companies can get the most out of agency interactions\, and strategies to lower risks and avoid regulatory surprises. \nRegister for free today and secure your spot for this important virtual event.
URL:https://thebiocalendar.com/event/fda-engagement-strategies-and-best-practices-amid-agency-changes/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/26_08-LSL-HTML-600x300-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260820T110000
DTEND;TZID=America/Los_Angeles:20260820T120000
DTSTAMP:20260725T055023Z
CREATED:20260724T110739Z
LAST-MODIFIED:20260725T055023Z
UID:10851-1787223600-1787227200@thebiocalendar.com
SUMMARY:CAR-T for Relapsed/Refractory AML: From Discovery to First-in-Human Active Phase 1 Evaluation
DESCRIPTION:Join Dr. Marco Davila to explore a novel anti-CD83 CAR-T design for relapsed/refractory AML that overcomes myelosuppression barriers. Register for the live session. \nDeveloping effective Chimeric Antigen Receptor (CAR) T-cell therapies for Acute Myeloid Leukemia (AML) remains one of the most formidable frontiers in cellular immunotherapy. Unlike lymphoid malignancies where lineage-specific targets like CD19 or BCMA offer a clear therapeutic window\, AML presents a severe biological bottleneck. The vast majority of well-characterized myeloid antigens (such as CD33 or CD123) are shared with healthy hematopoietic stem and progenitor cells (HSPCs). Consequently\, conventional CAR-T approaches frequently induce prolonged\, life-threatening myelosuppression and bone marrow aplasia severely limiting their clinical utility. This webinar by Dr. Marco Davila will explore a paradigm-shifting strategy developed at Roswell Park Comprehensive Cancer Center that addresses this exact barrier: a novel CAR-T design targeting the CD83 antigen. \nOur discussion will center on the unique biology of CD83\, a protein highly expressed on malignant AML blasts but distinctively regulated in healthy tissues\, offering a pathway to selectively suppress leukemia cells while sparing critical progenitor stem cells. Moving from bench to bedside\, we will detail the rigorous process development and GMP manufacturing frameworks involved in generating this CAR-T cell therapy to be tested in clinic. Finally\, we will share insights into the initiation and objectives of the first-of-its-kind\, active Phase 1 clinical trial evaluating autologous anti-CD83 CAR-T cell infusions in patients with relapsed or refractory AML. Join us to discover how this dual-action architecture reshapes safety\, efficacy\, and translation benchmarks in the myeloid cell therapy space.
URL:https://thebiocalendar.com/event/car-t-for-relapsed-refractory-aml-from-discovery-to-first-in-human-active-phase-1-evaluation/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-20-26-Miltenyi-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260820T110000
DTEND;TZID=America/Los_Angeles:20260820T120000
DTSTAMP:20260812T144002Z
CREATED:20260729T150317Z
LAST-MODIFIED:20260812T144002Z
UID:10888-1787223600-1787227200@thebiocalendar.com
SUMMARY:Where Precision Drives Progress: Meeting the Rising Complexity of Modern Clinical Trials
DESCRIPTION:Explore how leading teams are using trusted data and targeted AI to design\, plan\, and execute trials with the confidence today’s science requires. \nLearning outcomes:\n– Understand what’s driving trial complexity\n– Design protocols with confidence using real data + AI\n– Select sites based on holistic drivers of outcomes; access\, experience and past performance\n– Rethink patient recruitment as the critical success factor\n– Align with evolving regulatory expectations (ICH GCP E6 R3)
URL:https://thebiocalendar.com/event/where-precision-drives-progress-meeting-the-rising-complexity-of-modern-clinical-trials/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-20-26-Citeline-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260820T110000
DTEND;TZID=America/Los_Angeles:20260820T133000
DTSTAMP:20260806T155048Z
CREATED:20260721T181456Z
LAST-MODIFIED:20260806T155048Z
UID:10823-1787223600-1787232600@thebiocalendar.com
SUMMARY:BVS’ Biotech Community Event at The Alexandria at Torres Pines\, San Diego
DESCRIPTION:Venue Update: Due to the hot weather\, the event has been moved to a new indoor location: Farmer & The Seahorse\, The Alexandria\, 10996 Torreyana Rd\, San Diego\, CA 92121 \nWe are very excited to announce our indoor Biotech Community Event at the Farmer & The Seahorse at The Alexandria at Torrey Pines. \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \n✨ What to Expect: \n    Vendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\n    Networking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\n    Delicious Lunch & Drinks: Enjoy a delicious lunch as you network and explore the vendor exhibits. \nWe are inviting all the tenants and all local life science researchers and entrepreneurs in the surrounding area to attend. \nAdmission Details:\nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-biotech-community-event-at-one-alexandria-square-san-diego/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Trade Show
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/07/BVS-Biotech-Event-Flyer-08-20-26-2.jpg
END:VEVENT
END:VCALENDAR